Northwest Biotherapeutics, Inc. Common stock
NWBO
NWBO was delisted on the 16th of December, 2016.
5 hedge funds and large institutions have $39K invested in Northwest Biotherapeutics, Inc. Common stock in 2019 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, reducing their positions, and 2 closing their positions.
15% more capital invested
Capital invested by funds: $34K → $39K (+$5K)
17% less funds holding
Funds holding: 6 → 5 (-1)
50% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WPP
Whalerock Point Partners
Providence,
Rhode Island
|
+$3.02K |
| 2 |
CAPTRUST Financial Advisors
Raleigh,
North Carolina
|
+$3K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HNB
Huntington National Bank
Columbus,
Ohio
|
-$5K |
| 2 |
HAG
HighPoint Advisor Group
Downers Grove,
Illinois
|
-$4K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
SAM
1
Seelaus Asset Management
Chatham,
New Jersey
| $14K | – | – | – |
|
|
WPP
2
Whalerock Point Partners
Providence,
Rhode Island
| $14K | +$3.02K | +11,000 | +28% |
|
|
LDB
3
Lee, Danner & Bass
Nashville,
Tennessee
| $5K | – | – | – |
|
|
MPI
4
Mairs & Power Inc
St Paul,
Minnesota
| $3K | – | – | – |
|
|
5
CAPTRUST Financial Advisors
Raleigh,
North Carolina
| $3K | +$3K | +9,200 | New |
|
|
HNB
6
Huntington National Bank
Columbus,
Ohio
| – | -$5K | -25,000 | Closed |
|
|
HAG
7
HighPoint Advisor Group
Downers Grove,
Illinois
| – | -$4K | -19,450 | Closed |
|
NWBO Hedge Fund Activity: Q1 2019 in Review
5 of the 4,621 institutional investors tracked by Wall St. Rank reported a position in Northwest Biotherapeutics, Inc. Common stock (NWBO) for Q1 2019, worth a combined $39K — up 15% from $34K a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of NWBO and 1 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 1 added.
The largest buyer was Whalerock Point Partners, adding an estimated $3.02K. The largest seller was Huntington National Bank, exiting entirely with an estimated $5K sold.
- 5 institutional investors held Northwest Biotherapeutics, Inc. Common stock (NWBO) as of Q1 2019, down from 6 in Q4 2018.
- Funds reported $39K of Northwest Biotherapeutics, Inc. Common stock stock for Q1 2019, up 15% quarter-over-quarter.
- 1 fund opened new Northwest Biotherapeutics, Inc. Common stock positions in Q1 2019 and 2 closed out, a net change of -1 holder.
- The largest Northwest Biotherapeutics, Inc. Common stock buyer in Q1 2019 was Whalerock Point Partners, an estimated $3.02K added.
- The largest Northwest Biotherapeutics, Inc. Common stock seller in Q1 2019 was Huntington National Bank, an estimated $5K sold.
Based on aggregated 13F filings for Q1 2019.